Relapsing Remitting Ms (rrms) - Neurology

Relevant Publications

Evolution of retinal degeneration and prediction of disease activity in relapsing and progressive multiple sclerosis.

Issue Release: 2024

[Optical coherence tomography in the diagnosis of multiple sclerosis].

Issue Release: 2024

Exploring miRNAs\' Based Modeling Approach for Predicting PIRA in Multiple Sclerosis: A Comprehensive Analysis.

Issue Release: 2024

Serum Concentrations of Chemokines CCL20, CXCL8 and CXCL10 in Relapsing-Remitting Multiple Sclerosis and Their Association with Presence of Antibodies against Epstein-Barr Virus.

Issue Release: 2024

Ongoing randomized clinical trials on HSCT in multiple sclerosis.

Issue Release: 2024

Decisional Conflict Regarding Disease-Modifying Treatment Choices Among Patients with Mid-Stage Relapsing-Remitting Multiple Sclerosis.

Issue Release: 2024

Association of Cortical Lesions With Regional Glutamate, GABA, -Acetylaspartate, and Myoinositol Levels in Patients With Multiple Sclerosis.

Issue Release: 2024

Choroid plexus enlargement is associated with future periventricular neurodegeneration in multiple sclerosis.

Issue Release: 2024

Optical coherence tomography angiography suggests different retinal pathologies in multiple sclerosis and Sjögren\'s syndrome.

Issue Release: 2024

Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis.

Issue Release: 2024

TAURUS-MS II: real-world use of teriflunomide in Germany and changes in treatment patterns over time.

Issue Release: 2024

Assessment of serum inflammatory parameters in RRMS and SPMS patients.

Issue Release: 2024

Altered cerebrospinal fluid neurofilament light chain but not neurogranin levels are associated with response to ocrelizumab treatment in relapsing remitting multiple sclerosis: a preliminary study.

Issue Release: 2024

[Optical coherence tomography angiography in the diagnosis of multiple sclerosis].

Issue Release: 2024

Utilization of peginterferon-β-1a in the real-world practice for relapsing-remitting multiple sclerosis.

Issue Release: 2024

Adaptive and Innate Immunity Are Key Drivers of Age at Onset of Multiple Sclerosis.

Issue Release: 2024

Analysis of potential microRNA biomarkers for multiple sclerosis.

Issue Release: 2024

Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis.

Issue Release: 2024

Age-related decline in cerebral oxygen consumption in multiple sclerosis.

Issue Release: 2024

Common Social and Health Disparities Contribute to Racial Differences in Ambulatory Impairment in Multiple Sclerosis.

Issue Release: 2024

What Causes MS?

Why are Preoperative Evaluations Important?

How is Cognitive Function Assessed?

How Does DBS Work?

What Treatment Options are Available?

What Are the Expected Outcomes of Neurorehabilitation?

How does PCOS affect neurological function?

How Do Wearable Devices Improve Neurological Care?

How Does Deep Brain Stimulation Work?

Can the Mediterranean Diet Reduce the Risk of Neurodegenerative Diseases?

Partnered Content Networks

Relevant Topics